Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

UBX

Unity Biotechnology Inc

Apr 15 • 04:00PM ET

1.50

Dollar change -0.02
Percentage change -1.32	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.65	Insider Own	8.66%	Shs Outstand	16.79M	Perf Week	-3.85%
Market Cap	25.18M	Forward P/E	-	EPS next Y	-1.30	Insider Trans	-0.24%	Shs Float	15.33M	Perf Month	0.00%
Income	-52.53M	PEG	-	EPS next Q	-	Inst Own	18.69%	Short Float	2.00%	Perf Quarter	-19.35%
Sales	0.00M	P/S	-	EPS this Y	32.96%	Inst Trans	116.21%	Short Ratio	3.36	Perf Half Y	-10.71%
Book/sh	2.48	P/B	0.61	EPS next Y	28.18%	ROA	-51.08%	Short Interest	0.31M	Perf Year	-23.08%
Cash/sh	2.74	P/C	0.55	EPS next 5Y	-	ROE	-91.54%	52W Range	1.50 - 3.82	Perf YTD	-22.28%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.63%	ROI	-86.63%	52W High	-60.73%	Beta	0.87
Dividend TTM	-	Quick Ratio	5.74	Sales past 5Y	-	Gross Margin	-697.46%	52W Low	0.00%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	5.74	EPS Y/Y TTM	53.62%	Oper. Margin	0.00%	RSI (14)	37.57	Volatility	3.71% 4.33%
Employees	-	Debt/Eq	0.67	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	6.00
Option/Short	Yes / Yes	LT Debt/Eq	0.67	EPS Q/Q	23.05%	Payout	-	Rel Volume	0.37	Prev Close	1.52
Sales Surprise	-	EPS Surprise	53.83%	Sales Q/Q	-	Earnings	Apr 15 BMO	Avg Volume	91.31K	Price	1.50
SMA20	-4.06%	SMA50	-10.22%	SMA200	-27.38%	Trades		Volume	33,480	Change	-1.32%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-16-23	Upgrade	Wedbush	Neutral → Outperform	$2 → $4
Jan-04-22	Upgrade	ROTH Capital	Neutral → Buy
Nov-10-21	Upgrade	Mizuho	Neutral → Buy	$5 → $7
Jun-28-21	Upgrade	Citigroup	Sell → Buy	$6
Jun-07-21	Initiated	H.C. Wainwright	Buy	$12
Feb-16-21	Downgrade	Citigroup	Neutral → Sell	$5 → $6
Aug-18-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$5
Aug-18-20	Downgrade	Mizuho	Buy → Neutral	$33 → $4
Aug-18-20	Downgrade	Citigroup	Buy → Neutral	$31 → $5
Aug-17-20	Downgrade	ROTH Capital	Buy → Neutral
Jul-28-20	Initiated	ROTH Capital	Buy	$35
Dec-12-19	Initiated	Cantor Fitzgerald	Overweight	$20
Mar-07-19	Initiated	Cantor Fitzgerald	Overweight	$21
Sep-07-18	Initiated	Mizuho	Buy
May-29-18	Initiated	Morgan Stanley	Overweight	$25
May-29-18	Initiated	Goldman	Neutral	$17
May-29-18	Initiated	Citigroup	Buy	$32

Show Previous Ratings

Apr-15-24 11:52AM	UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023 (InvestorPlace)
07:00AM	UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
Feb-06-24 08:00AM	New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss (GlobeNewswire)
Dec-29-23 04:37PM	10 Supplements for Longevity and Antiaging: Expert Recommendations (Insider Monkey)
Dec-12-23 08:00AM	UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME (GlobeNewswire)
04:05PM	Loading…
Nov-13-23 04:05PM	UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
Nov-10-23 08:00AM	UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds (GlobeNewswire) -6.25%
Oct-17-23 05:14PM	Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks (InvestorPlace) +17.86%
Oct-03-23 09:36PM	20 Foods Consumed By Longest Living People Every Day (Insider Monkey)
Sep-27-23 07:00AM	UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration (GlobeNewswire)
Sep-16-23 01:02AM	Unity Biotechnology Inc CEO Anirvan Ghosh Sells 1,246 Shares (GuruFocus.com)
Aug-15-23 04:51PM	20 States With The Longest Life Expectancy In America (Insider Monkey)
Aug-08-23 04:05PM	UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
Jun-21-23 07:00AM	UNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME) (GlobeNewswire)
May-09-23 04:05PM	UNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
01:34PM	Loading…
Apr-24-23 01:34PM	Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea (Benzinga) -5.19%
07:00AM	UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema (GlobeNewswire)
Apr-23-23 06:00PM	UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema (GlobeNewswire)
Mar-28-23 03:25PM	Unity (UNX) Down on Disappointing Results From Wet AMD Study (Zacks) -10.26%
Mar-27-23 01:28PM	UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug (Benzinga) -53.01%
07:30AM	UNITY Biotechnology Announces Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration (GlobeNewswire)
Mar-15-23 04:05PM	UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire)
Feb-28-23 04:05PM	UNITY Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-15-23 08:00AM	UNITY Biotechnology to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire) +10.74%
Feb-09-23 08:00AM	UNITY Biotechnology to Host Investor Call to Review Data from the UBX1325 Program and Provide an Overview of the ENVISION Wet AMD Study (GlobeNewswire)
Jan-18-23 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Award (GlobeNewswire) +7.32%
Jan-10-23 10:36AM	10 Penny Stocks That Will Make You A Millionaire (Insider Monkey) +9.48%
Nov-08-22 04:10PM	UNITY Biotechnology, Inc. Reports Third Quarter 2022 Financial Results and Business Updates (GlobeNewswire)
Nov-01-22 07:00AM	UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema (GlobeNewswire)
Oct-31-22 06:11PM	UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema (GlobeNewswire) +12.60%
08:30AM	Loading…
Oct-19-22 08:30AM	UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today (GlobeNewswire) -14.49%
Oct-11-22 08:00AM	UNITY Biotechnologys Investor and Analyst Day to Highlight UBX1325 Program in Age-Related Diseases of the Eye (GlobeNewswire) -5.34%
Oct-10-22 12:00PM	All You Need to Know About UNITY Biotechnology, Inc. (UBX) Rating Upgrade to Strong Buy (Zacks)
Oct-06-22 08:00AM	UNITY Biotechnology to Host Investor and Analyst Day to Discuss Clinical Development Program for UBX1325 in Age-Related Diseases of the Eye (GlobeNewswire)
Sep-19-22 08:00AM	UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular Degeneration (GlobeNewswire)
07:00AM	The Three Best Anti-Aging Stocks to Buy in September (InvestorPlace)
Aug-31-22 08:00AM	UNITY Biotechnology to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.18%
Aug-30-22 09:55AM	Bears are Losing Control Over UNITY Biotechnology, Inc. (UBX), Here's Why It's a 'Buy' Now (Zacks)
Aug-17-22 11:04PM	UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering (GlobeNewswire) -29.19%
Aug-16-22 04:01PM	UNITY Biotechnology Announces Proposed Public Offering of Common Stock (GlobeNewswire) +6.20%
Aug-12-22 09:18AM	UNITY Biotech Shares More Than Double On Positive Drug Data For Diabetes Associated Vision Loss (Benzinga) +54.10%
07:05AM	UNITY Biotechnology, Inc. Reports Second Quarter 2022 Financial Results and Business Updates (GlobeNewswire)
07:00AM	UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema (GlobeNewswire)
Aug-11-22 05:45PM	UNITY Biotechnology to Host Investor Call on 12- and 18-week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with DME (GlobeNewswire) -12.36%
Jul-12-22 04:00PM	UNITY Biotechnology to Present Clinical Data at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting (GlobeNewswire) +5.93%
Jun-29-22 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Award (GlobeNewswire)
May-26-22 08:00AM	UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors (GlobeNewswire)
May-25-22 08:00AM	UNITY Biotechnology to Participate in the UBS 2022 Global Healthcare Conference (GlobeNewswire)
May-10-22 04:00PM	UNITY Biotechnology, Inc. Reports First Quarter 2022 Financial Results and Business Updates (GlobeNewswire)
May-05-22 08:00AM	UNITY Biotechnology Presentations at ARVO 2022 Showcase UBX1325 as an Investigational Novel Therapeutic Modality for Retinal Vascular Diseases (GlobeNewswire) -6.95%
Apr-21-22 08:00AM	UNITY Biotechnology to Present Clinical Data at the Association for Research in Vision & Ophthalmology (ARVO) 2022 Annual Meeting (GlobeNewswire)
Apr-19-22 08:00AM	UNITY Biotechnology Doses First Patient in ENVISION, the Phase 2 Study of UBX1325 in Wet Age-Related Macular Degeneration (GlobeNewswire)
Apr-12-22 08:00AM	UNITY Biotechnology Completes Enrollment in BEHOLD, the Phase 2 Study of Senolytic Candidate UBX1325 in Diabetic Macular Edema (GlobeNewswire)
Mar-17-22 12:51PM	Investors in Unity Biotechnology (NASDAQ:UBX) from three years ago are still down 88%, even after 23% gain this past week (Simply Wall St.) +6.86%
Mar-15-22 08:00AM	UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates (GlobeNewswire) +6.36%
Mar-01-22 08:00AM	UNITY Biotechnology to Participate in the Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-14-22 08:00AM	UNITY Biotechnology Announces Additional Data from Phase 1 Study of UBX1325 in Advanced Vascular Eye Disease (GlobeNewswire) +7.10%
Feb-03-22 06:00PM	Anti-aging company Unity Biotechnology to axe half its staff, focus on eye drugs (American City Business Journals) -9.40%
04:01PM	UNITY Biotechnology Announces Restructuring to Advance Corporate Strategy and Focus on Key Ophthalmology Programs (GlobeNewswire)
Feb-02-22 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Award (GlobeNewswire) -7.87%
Jan-25-22 05:38PM	Arbor Wealth Management, LLC Buys Wells Fargo, Activision Blizzard Inc, Amcor PLC, Sells Altice ... (GuruFocus.com)
Jan-04-22 08:00AM	UNITY Biotechnology Provides Program Updates and Anticipated Milestones for 2022 (GlobeNewswire) +6.29%
Dec-22-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Award (GlobeNewswire)
Dec-20-21 08:00AM	UNITY Biotechnology Announces Exclusive License Agreement with Jocasta Neuroscience to Continue Development of -Klotho Program (GlobeNewswire) -5.00%
Nov-10-21 12:35PM	Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases? (Benzinga) +23.35%
08:00AM	UNITY Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates (GlobeNewswire)
Nov-09-21 07:00AM	UNITY Biotechnology Announces Improvement in Visual Acuity Sustained Through 24 Weeks Following Single Dose of UBX1325 in Phase 1 Study of Patients with Advanced Vascular Eye Disease (GlobeNewswire) +8.90%
Nov-03-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire) -8.99%
Oct-06-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire) -5.64%
Oct-05-21 12:15PM	Mid-Day Market Update: Crude Oil Rises 2%; UpHealth Shares Plunge (Benzinga)
07:00AM	UNITY Biotechnology Announces Positive 12-Week Data from Phase 1 Clinical Trial of UBX1325 in Advanced Vascular Eye Disease (GlobeNewswire)
Oct-04-21 01:00AM	Hedge Funds Are Piling Into Unity Biotechnology, Inc. (UBX) (Insider Monkey) -5.76%
Sep-07-21 04:00PM	UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-18-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Aug-16-21 04:03PM	UNITY Biotechnology, Inc. to Participate in the H.C. Wainwright Ophthalmology Virtual Conference (GlobeNewswire)
Aug-10-21 04:01PM	UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business Updates (GlobeNewswire)
Jul-28-21 07:40PM	Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325 (PR Newswire)
08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Jul-23-21 08:00AM	UNITY Biotechnology to Host Investor Call with Retinal Expert Robert Bhisitkul, M.D., Ph.D., to Discuss Recent Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease (GlobeNewswire)
Jul-06-21 08:59AM	Unity Biotech's UBX1325 Shows Initial Efficacy With Improved Vision, Structure In Vascular Eye Disease (Benzinga)
07:00AM	UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease (GlobeNewswire)
Jun-18-21 03:03PM	Is Unity Biotechnology, Inc. (UBX) A Good Stock To Buy? (Insider Monkey)
Jun-08-21 08:25AM	Is Unity Biotechnology, Inc. (NASDAQ:UBX) Popular Amongst Institutions? (Simply Wall St.)
Jun-02-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
May-11-21 08:00AM	UNITY Biotechnology, Inc. Reports First Quarter 2021 Financial Results and Business Updates (GlobeNewswire)
May-01-21 07:00AM	UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases (GlobeNewswire)
Apr-28-21 08:00AM	UNITY Biotechnology to Present Preclinical Data on Clinical Candidate Molecule UBX1325 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting (GlobeNewswire)
Apr-21-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Mar-23-21 04:01PM	UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates (GlobeNewswire) -7.76%
Mar-11-21 04:05PM	UNITY Biotechnology Reports Granting of New Employment Inducement Award (GlobeNewswire) +5.54%
Mar-08-21 08:00AM	UNITY Biotechnology Announces Appointment of Alexander Nguyen as General Counsel (GlobeNewswire)
Feb-26-21 04:05PM	UNITY Biotechnology to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-24-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Feb-08-21 08:00AM	Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease (GlobeNewswire) +6.92%
Feb-03-21 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Feb-01-21 08:00AM	UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor (GlobeNewswire) +8.12%
Jan-12-21 10:44AM	Are Options Traders Betting on a Big Move in Unity Biotechnology (UBX) Stock? (Zacks) +5.32%
Dec-22-20 07:45AM	The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes (Benzinga) +6.04%
Dec-16-20 08:00AM	UNITY Biotechnology Reports Granting of New Employment Inducement Awards (GlobeNewswire)
Dec-14-20 07:00AM	UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore ONeill, M.B., to the Board of Directors (GlobeNewswire)

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ghosh Anirvan	Chief Executive Officer	Feb 02 '24	Sale	1.71	680	1,163	78,746	Feb 05 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Jan 30 '24	Sale	1.71	1,183	2,023	79,426	Jan 31 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Nov 02 '23	Sale	1.83	589	1,078	80,609	Nov 03 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Oct 30 '23	Sale	1.90	1,024	1,946	81,198	Oct 31 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Sep 14 '23	Sale	2.47	1,246	3,078	82,222	Sep 15 04:08 PM
Ghosh Anirvan	Chief Executive Officer	Aug 02 '23	Sale	2.94	581	1,708	83,468	Aug 03 04:13 PM
Ghosh Anirvan	Chief Executive Officer	Jul 31 '23	Sale	2.86	1,020	2,917	84,049	Aug 01 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Jun 26 '23	Sale	3.20	1,177	3,766	85,069	Jun 27 05:10 PM
Ghosh Anirvan	Chief Executive Officer	Jun 14 '23	Sale	3.39	1,212	4,109	86,246	Jun 15 05:58 PM
Ghosh Anirvan	Chief Executive Officer	May 02 '23	Sale	2.17	588	1,276	87,458	May 03 05:26 PM
Ghosh Anirvan	Chief Executive Officer	May 01 '23	Sale	2.15	1,020	2,193	88	May 02 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

UBX

Unity Biotechnology Inc

Upgrade your FINVIZ experience